Succinic Acid

Succinic Acid

SCHEMBL1705784

COc1ccccc1C(c1ccccc1)(c1ccccc1OC)[C@]1(n2cc(C)c(=O)[nH]c2=O)C[C@H](O)[C@@H](CO)O1.O=C(O)CCC(=O)O

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
RNASE1 P07998 1/20 0.37
TK1 P04183 5/20 0.34
TOP2A P11388 1/20 0.34
TK2 O00142 2/20 0.33
TYMP P19971 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1706305 0.96 RNASE1 (0.38) RNASE1TK1TOP2ATK2
SCHEMBL9755145 0.94 RNASE1 (0.38) RNASE1TK1TOP2ATK2
SCHEMBL1705935 0.92 RNASE1 (0.35) RNASE1TK1TOP2ATK2
SCHEMBL8920654 0.90 RNASE1 (0.36) RNASE1TK1TOP2ATK2
SCHEMBL7640415 0.88 RNASE1 (0.38) RNASE1TK1TK2
SCHEMBL20636773 0.87 LMNA (0.38) RNASE1TOP2A
SCHEMBL3612838 0.87 TK1 (0.38) RNASE1TK1
SCHEMBL1727535 0.87 RNASE1 (0.40) RNASE1TK1TK2
SCHEMBL8370048 0.85 RNASE1 (0.38) RNASE1TK1TK2
SCHEMBL7863893 0.83 RNASE1 (0.37) RNASE1TK1TOP2ATK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8825411-B2 Design, synthesis and assembly of synthetic nucleic acids DNA TWOPOINTO, INC. (US) 2014-09-02 US disclosed
EP-2441769-B1 Design, synthesis and assembly of synthetic nucleic acids REPLIGEN CORP (US) 2014-05-07 EP disclosed
US-20130196864-A1 DESIGN, SYNTHESIS AND ASSEMBLY OF SYNTHETIC NUCLEIC ACIDS DNA TWOPOINTO, INC. (US) 2013-08-01 US disclosed
EP-2441769-A1 Design, synthesis and assembly of synthetic nucleic acids REPLIGEN CORPORATION (US) 2012-04-18 EP disclosed
US-20090317873-A1 Design, synthesis and assembly of synthetic nucleic acids DNA TWOPOINTO, INC. 2009-12-24 US disclosed
US-20080300842-A1 Design, Synthesis and Assembly of Synthetic Nucleic Acids NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-12-04 US disclosed
EP-1771579-A2 DESIGN, SYNTHESIS AND ASSEMBLY OF SYNTHETIC NUCLEIC ACIDS DNA TWOPOINTO INC. (US) 2007-04-11 EP disclosed
WO-2005115102-A2 DESIGN, SYNTHESIS AND ASSEMBLY OF SYNTHETIC NUCLEIC ACIDS DNA TWOPOINTO, INC. (US) 2005-12-08 WO disclosed
WO-1994001446-A2 DERIVATIZED ORGANIC SOLID SUPPORT FOR NUCLEIC ACID SYNTHESIS BECKMAN INSTRUMENTS, INC. (US) 1994-01-20 WO disclosed